58420-21-6

Basic information

• Product Name: 3-(4-ISOPROPYLPHENYL)PROPIONIC ACID
• Synonyms: 3-(4-ISOPROPYLPHENYL)PROPIONIC ACID;4-Isopropylbenzenepropanoic acid
• CAS NO: 58420-21-6
• Molecular Formula: C₁₂H₁₆O₂
• Molecular Weight: 192.25
• Mol File: 58420-21-6.mol
• Article Data: 6

Chemical Properties

• Melting Point: 74-76°C
• Boiling Point: 310.5°Cat760mmHg
• Flash Point: 207.6°C
• Appearance: /
• Density: 1.047g/cm³
• Vapor Pressure: 0.000257mmHg at 25°C
• Refractive Index: 1.524
• PKA: 4.69±0.10(Predicted)
• CAS DataBase Reference: 3-(4-ISOPROPYLPHENYL)PROPIONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-ISOPROPYLPHENYL)PROPIONIC ACID(58420-21-6)
• EPA Substance Registry System: 3-(4-ISOPROPYLPHENYL)PROPIONIC ACID(58420-21-6)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 36/37/38-22
• Safety Statements: 26-36/37/39
• HazardClass: IRRITANT
• Hazardous Substances Data: 58420-21-6(Hazardous Substances Data)

Usage

Uses

3-(4-Isopropylphenyl)propionic Acid is a para substituted benzene with antiviral properties.Also, it is used in the synthesis of a cytotoxic natural ester sintenin and twenty eight analogs including nitrogen-containing heterocyclic indole groups.

InChI:InChI=1/C12H16O2/c1-9(2)11-6-3-10(4-7-11)5-8-12(13)14/h3-4,6-7,9H,5,8H2,1-2H3,(H,13,14)

Upstream product

• 3368-21-6 4-isopropylcinnamic acid 
• 32580-69-1 4-isopropyl-cinnamic acid ethyl ester 
• 122-03-2 (4-isopropylbenzaldehyde) 
• 2033-24-1 cycl-isopropylidene malonate 
• 64-18-6 formic acid 
• 97438-47-6 Acetic acid (E)-3-(4-isopropyl-phenyl)-propenyl ester 
• 98-82-8 Isopropylbenzene 
• 2051-18-5 4-isopropylbenzyl chloride 
• 59577-61-6 (4-isopropyl-benzylidene)-malonic acid 
• 3368-21-6 (E)-4-isopropylcinnamic acid 
• 64-17-5 ethanol 
• 7775-00-0 3-(4'-isopropylphenyl)propanal 
• 4441-89-8 (4-isopropyl-benzyl)-malonic acid 
• 4638-83-9 -essigsaeure 

Downstream Products

• 42348-89-0 6-isopropylindan-1-one 
• 38628-51-2 3-(4-carboxyphenyl)propionic acid 
• 181954-87-0 3-(4-isopropyl-phenyl)-propionyl chloride 
• 1028316-87-1 2-[3-(4-Isopropyl-phenyl)-propyl]-thiophene 
• 214618-09-4 5-{5-[3-(4-Isopropyl-phenyl)-propyl]-thiophen-2-yl}-3,3-dimethyl-pentanoic acid 
• 1026263-58-0 5-{5-[3-(4-Isopropyl-phenyl)-propyl]-thiophen-2-yl}-3,3-dimethyl-5-oxo-pentanoic acid 
• 1027090-68-1 5-{5-[3-(4-Isopropyl-phenyl)-propyl]-thiophen-2-yl}-3,3-dimethyl-1-[4-(2,3,4-trimethoxy-benzyl)-piperazin-1-yl]-pentan-1-one 
• 63457-76-1 1,5-di-(4-isopropyl-phenyl)-3-pentanone 
• 918519-17-2 C₁₄H₂₁NO₂ 
• 79942-40-8 3-(4-isopropylphenyl)-2-methylpropanol 
• 1226107-55-6 C₁₈H₂₁NO₂ 
• 697306-31-3 3-(4-carboxy-2-nitro-phenyl)-propionic acid 
• 88371-24-8 1,2,3,4-tetrahydro-2-oxo-7-quinolinecarboxylic acid 
• 1027397-80-3 2-Benzylamino-7-isopropyl-1,2,3,4-tetrahydro-naphthalene-2-carbonitrile 

Relevant articles and documents

METHODS OF SYNTHESIZING FARNESYL DIBENZODIAZEPINONES

The present invention is directed to synthetic means for producing farnesyl dibenzodiazepinone compounds, including AMO-01.

Ansa-Ruthenium(II) Complexes of R2NSO2DPEN-(CH2)n(η6-Aryl) Conjugate Ligands for Asymmetric Transfer Hydrogenation of Aryl Ketones

New 3rd generation designer ansa-ruthenium(II) complexes featuring N,C-alkylene-tethered N,N-dialkylsulfamoyl-DPEN/η6-arene ligands, exhibited good catalytic performance in the asymmetric transfer hydrogenation (ATH) of various classes of (het)aryl ketones in formic acid/triethylamine mixture. In particular, benzo-fused cyclic ketones furnished 98 to >99.9% ee using a low catalyst loading.

QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS

Use of a compound for the manufacture of a medicament for the treatment of a bacterial infection provided that the bacterial infection is other than a Mycobacterial infection, said compound being a compound of formula (Ia) or (Ib) a pharmaceutically acceptable acid or base addition salt thereof, a stereochemically isomeric form thereof, a tautomeric form thereof or a N-oxide form thereof. Several of these compounds are also claimed as such. Further the combination of the above compounds with other antibacterial agents is described